Literature DB >> 10494087

Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy.

E Takai1, H Akita, N Shiga, K Kanazawa, S Yamada, M Terashima, Y Matsuda, C Iwai, K Kawai, Y Yokota, M Yokoyama.   

Abstract

Dilated cardiomyopathy (DCM) results in part from genetic disorders. Recently, missense mutations of the cardiac actin gene have been reported to cause DCM. We studied 136 Japanese DCM cases to elucidate how frequently the gene mutations are involved in its pathogenesis. Genomic DNA samples were obtained from 136 DCM cases (107 males, 29 females), containing 30 familial DCM (5 confirmed and 25 suspected). All six exons of the cardiac actin gene were analyzed by polymerase chain reaction, single-strand conformation polymorphism, and sequencing. We detected no mutations of the disease causation previously reported (G867A or A1014G) but two silent mutations (G979C and C1018T) in exon 6 and one point mutation (T1080A) in the 3'-untranslated region. As a result of screening 128 healthy subjects, these novel silent mutations were found to be mere genetic polymorphisms, not responsible for the disease. Although some genetic polymorphisms exist in the cardiac actin gene, mutations of the gene are rarely responsible for DCM, at least in the Japanese patients. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10494087     DOI: 10.1002/(sici)1096-8628(19991008)86:4<325::aid-ajmg5>3.0.co;2-u

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 2.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Ray E Hershberger; Jill D Siegfried
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

3.  Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.

Authors:  E L Hanson; R E Hershberger
Journal:  J Genet Couns       Date:  2001-10       Impact factor: 2.537

4.  Identification of hub genes and pathways in bladder cancer using bioinformatics analysis.

Authors:  Danhui Li; Fan Zhen; Jianwei Le; Guodong Chen; Jianhua Zhu
Journal:  Am J Clin Exp Urol       Date:  2022-02-15

5.  Genetic variations of α-cardiac actin and cardiac muscle LIM protein in hypertrophic cardiomyopathy in South India.

Authors:  Advithi Rangaraju; Deepa Selvi Rani; Ml Satyanarayana; Narasimhan Calambur; Nalla Swapna; Pratibha Nallari
Journal:  Exp Clin Cardiol       Date:  2012

6.  Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.

Authors:  Ray E Hershberger; Ana Morales; Jill D Siegfried
Journal:  Genet Med       Date:  2010-11       Impact factor: 8.822

Review 7.  Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy.

Authors:  Matthias Eden; Norbert Frey
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

Review 8.  Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic Diagnostics.

Authors:  Hyun-Young Park
Journal:  Korean Circ J       Date:  2017-02-21       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.